Long-term effectiveness of levodopa-carbidopa intestinal gel in 177 Spanish patients with advanced Parkinson's disease
To assess long-term effectiveness and tolerability of levodopa-carbidopa intestinal gel (LCIG) in Spanish patients with advanced Parkinson's disease. This was an observational, multicenter, cross-sectional, retrospective study. Data of 177 patients were analyzed. LCIG treatment led to a reducti...
Gespeichert in:
Veröffentlicht in: | Neurodegenerative disease management 2016-08, Vol.6 (4), p.289-298 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | To assess long-term effectiveness and tolerability of levodopa-carbidopa intestinal gel (LCIG) in Spanish patients with advanced Parkinson's disease.
This was an observational, multicenter, cross-sectional, retrospective study.
Data of 177 patients were analyzed. LCIG treatment led to a reduction in the percentage of daily 'off' time (16.2 vs 47.6% before LCIG), an increase in the percentage of daily 'on' time without disabling dyskinesia (55.6 vs 21.6%). Most patients experienced improvements in freezing of gait, tremor, dizziness, fatigue or flat mood. Adverse events related to levodopa, gastrostomy and technical issues were reported in 36.2, 42.4 and 43.5% of patients, respectively.
This study confirms the long-term effectiveness and safety profile of LCIG in patients with advanced Parkinson's disease. |
---|---|
ISSN: | 1758-2024 1758-2032 |
DOI: | 10.2217/nmt-2016-0021 |